Ultra Seal Corporation recalls Cold Tablet Pain Reliever/Fever Reducer/Expectorant/Nasal Decongestant (acetaminophen 325 mg, Guaifenesin 200mg, Phenyle
Recalled February 9, 2022 · FDA recall D-0465-2022 · Ultra Seal
Hazard
cGMP deviations · FDA Class II
Units
313,000 packets
Sold at
Nationwide within the United States
Description
cGMP deviations
Product
Cold Tablet Pain Reliever/Fever Reducer/Expectorant/Nasal Decongestant (acetaminophen 325 mg, Guaifenesin 200mg, Phenylephrine HCl 5 mg) 2 tablets per packet, Mfg, for Respond Industries and American First Aid, Mason, OH 45040
Manufacturer(s)
Ultra Seal Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →